| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $79.5M | +109.4% |
| Cost of Revenue | $48.4M | +86.2% |
| R&D Expense | $68.8M | +36.8% |
| SG&A Expense | $61.6M | -21.4% |
| Operating Income | -$118.1M | +4.5% |
| Pre-tax Income | -$146.5M | -392.5% |
| Income Tax | -$517K | +97.7% |
| Net Income | -$145.4M | -296.8% |
| EPS (Basic) | -$0.86 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $152.8M | +38.5% |
| Accounts Receivable | $25.9M | +183.3% |
| Inventory | $23.2M | +21.5% |
| Current Assets | $208.5M | +46.7% |
| Total Assets | $485.5M | +14.2% |
| Current Liabilities | $50.4M | +147.6% |
| Total Liabilities | $104.9M | +159.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.1M | +9.9% |
| Capital Expenditures | $4.8M | +3.0% |
| Investing Cash Flow | -$5.8M | +94.6% |
| Financing Cash Flow | $88.4M | +1621.2% |
| Free Cash Flow | -$44.9M | +8.7% |
| -256.4% |
| EPS (Diluted) | -$0.86 | -268.6% |
| Stockholders' Equity |
| $380.6M |
| -0.1% |